{"transactions":[{"id":695698,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Series I Warrants","published_at":"2026-08-05T20:16:33.000Z","date":"2026-08-03","kind":"purchase","planned":false,"acquired":true,"shares":879999,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On August 3, 2026, the reporting person acquired 293,333 shares of common stock and Series I warrants to purchase 879,999 shares of common stock at a combined purchase price of $0.75 per one share of common stock and three accompanying warrants in a public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 3, 2026, the reporting person acquired 293,333 shares of common stock and Series I warrants to purchase 879,999 shares of common stock at a combined purchase price of $0.75 per one share of common stock and three accompanying warrants in a public offering."}],"balance_after":1027717,"derivative":{"exercise_date":"2026-08-03","expiration_date":"2031-08-03","underlying":"Common Stock","underlying_shares":879999},"source":{"system":"sec-edgar","filing":"0001437749-26-025929","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774926025929/rdgdoc.xml","form_type":"4"}},{"id":695697,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-05T20:16:33.000Z","date":"2026-08-03","kind":"purchase","planned":false,"acquired":true,"shares":293333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 3, 2026, the reporting person acquired 293,333 shares of common stock and Series I warrants to purchase 879,999 shares of common stock at a combined purchase price of $0.75 per one share of common stock and three accompanying warrants in a public offering."}],"balance_after":305673,"source":{"system":"sec-edgar","filing":"0001437749-26-025929","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774926025929/rdgdoc.xml","form_type":"4"}},{"id":696256,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Series I Warrants","published_at":"2026-08-05T20:16:13.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":1599999,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On August 3, 2026, the reporting person acquired 533,333 shares of common stock and Series I warrants to purchase 1,599,999 shares of common stock at a combined purchase price of $0.75 per one share of common stock and three accompanying warrants in a public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 3, 2026, the reporting person acquired 533,333 shares of common stock and Series I warrants to purchase 1,599,999 shares of common stock at a combined purchase price of $0.75 per one share of common stock and three accompanying warrants in a public offering."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On August 3, 2026, the reporting person acquired 533,333 shares of common stock and Series I warrants to purchase 1,599,999 shares of common stock at a combined purchase price of $0.75 per one share of common stock and three accompanying warrants in a public offering."}],"balance_after":1926335,"derivative":{"exercise_date":"2026-08-03","expiration_date":"2031-08-03","underlying":"Common Stock","underlying_shares":1599999},"source":{"system":"sec-edgar","filing":"0001437749-26-025928","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774926025928/rdgdoc.xml","form_type":"4"}},{"id":696255,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-08-05T20:16:13.000Z","date":"2026-08-03","kind":"purchase","planned":false,"acquired":true,"shares":533333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 3, 2026, the reporting person acquired 533,333 shares of common stock and Series I warrants to purchase 1,599,999 shares of common stock at a combined purchase price of $0.75 per one share of common stock and three accompanying warrants in a public offering."}],"balance_after":564340,"source":{"system":"sec-edgar","filing":"0001437749-26-025928","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774926025928/rdgdoc.xml","form_type":"4"}},{"id":695696,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26233,"kind":"person","name":"PICKER DONALD H","position":1,"cik":"0001266800","reported_name":"PICKER DONALD H","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Series I Warrants","published_at":"2026-08-05T20:15:48.000Z","date":"2026-08-03","kind":"purchase","planned":false,"acquired":true,"shares":519999,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On August 3, 2026, The reporting person acquired 173,333 shares of common stock and Series I warrants to purchase 519,999 shares of common stock at a combined purchase price of $0.75 per one share of common stock and three accompanying warrants in a public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 3, 2026, The reporting person acquired 173,333 shares of common stock and Series I warrants to purchase 519,999 shares of common stock at a combined purchase price of $0.75 per one share of common stock and three accompanying warrants in a public offering."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On August 3, 2026, The reporting person acquired 173,333 shares of common stock and Series I warrants to purchase 519,999 shares of common stock at a combined purchase price of $0.75 per one share of common stock and three accompanying warrants in a public offering."}],"balance_after":539595,"derivative":{"exercise_date":"2026-08-03","expiration_date":"2026-08-03","underlying":"Common Stock","underlying_shares":519999},"source":{"system":"sec-edgar","filing":"0001437749-26-025927","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774926025927/rdgdoc.xml","form_type":"4"}},{"id":695695,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26233,"kind":"person","name":"PICKER DONALD H","position":1,"cik":"0001266800","reported_name":"PICKER DONALD H","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2026-08-05T20:15:48.000Z","date":"2026-08-03","kind":"purchase","planned":false,"acquired":true,"shares":173333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 3, 2026, The reporting person acquired 173,333 shares of common stock and Series I warrants to purchase 519,999 shares of common stock at a combined purchase price of $0.75 per one share of common stock and three accompanying warrants in a public offering."}],"balance_after":174086,"source":{"system":"sec-edgar","filing":"0001437749-26-025927","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774926025927/rdgdoc.xml","form_type":"4"}},{"id":727621,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26233,"kind":"person","name":"PICKER DONALD H","position":1,"cik":"0001266800","reported_name":"PICKER DONALD H","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Restricted Stock Units","published_at":"2026-06-25T01:01:11.000Z","date":"2026-06-22","kind":"exercise","planned":false,"acquired":false,"shares":71,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On June 22, 2023, the reporting person was granted 283 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On June 22, 2023, the reporting person was granted 283 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":19596,"derivative":{"underlying":"Common Stock","underlying_shares":50},"source":{"system":"sec-edgar","filing":"0001437749-26-021612","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774926021612/rdgdoc.xml","form_type":"4"}},{"id":727620,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26233,"kind":"person","name":"PICKER DONALD H","position":1,"cik":"0001266800","reported_name":"PICKER DONALD H","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Restricted Stock Units","published_at":"2026-06-25T01:01:11.000Z","date":"2026-06-20","kind":"exercise","planned":false,"acquired":false,"shares":44,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 20, 2022, the reporting person was granted 173 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 20, 2022, the reporting person was granted 173 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":19667,"derivative":{"underlying":"Common Stock","underlying_shares":44},"source":{"system":"sec-edgar","filing":"0001437749-26-021612","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774926021612/rdgdoc.xml","form_type":"4"}},{"id":727619,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26233,"kind":"person","name":"PICKER DONALD H","position":1,"cik":"0001266800","reported_name":"PICKER DONALD H","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2026-06-25T01:01:11.000Z","date":"2026-06-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":21,"price":3.12,"value":65.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":753,"source":{"system":"sec-edgar","filing":"0001437749-26-021612","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774926021612/rdgdoc.xml","form_type":"4"}},{"id":727618,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26233,"kind":"person","name":"PICKER DONALD H","position":1,"cik":"0001266800","reported_name":"PICKER DONALD H","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2026-06-25T01:01:11.000Z","date":"2026-06-22","kind":"exercise","planned":false,"acquired":true,"shares":71,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":774,"source":{"system":"sec-edgar","filing":"0001437749-26-021612","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774926021612/rdgdoc.xml","form_type":"4"}},{"id":727617,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26233,"kind":"person","name":"PICKER DONALD H","position":1,"cik":"0001266800","reported_name":"PICKER DONALD H","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2026-06-25T01:01:11.000Z","date":"2026-06-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":13,"price":2.88,"value":37.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":703,"source":{"system":"sec-edgar","filing":"0001437749-26-021612","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774926021612/rdgdoc.xml","form_type":"4"}},{"id":727616,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26233,"kind":"person","name":"PICKER DONALD H","position":1,"cik":"0001266800","reported_name":"PICKER DONALD H","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2026-06-25T01:01:11.000Z","date":"2026-06-20","kind":"exercise","planned":false,"acquired":true,"shares":44,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":716,"source":{"system":"sec-edgar","filing":"0001437749-26-021612","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774926021612/rdgdoc.xml","form_type":"4"}},{"id":728159,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2026-06-25T01:00:45.000Z","date":"2026-06-22","kind":"exercise","planned":false,"acquired":false,"shares":360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On June 22, 2023, the reporting person was granted 1,439 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On June 22, 2023, the reporting person was granted 1,439 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 250,002 shares of common stock underlying Series E warrants to purchase common stock."}],"balance_after":326336,"derivative":{"underlying":"Common Stock","underlying_shares":360},"source":{"system":"sec-edgar","filing":"0001437749-26-021611","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774926021611/rdgdoc.xml","form_type":"4"}},{"id":728158,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2026-06-25T01:00:45.000Z","date":"2026-06-20","kind":"exercise","planned":false,"acquired":false,"shares":150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 20, 2022, the reporting person was granted 600 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 20, 2022, the reporting person was granted 600 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 250,002 shares of common stock underlying Series E warrants to purchase common stock."}],"balance_after":326696,"derivative":{"underlying":"Common Stock","underlying_shares":150},"source":{"system":"sec-edgar","filing":"0001437749-26-021611","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774926021611/rdgdoc.xml","form_type":"4"}},{"id":728157,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-06-25T01:00:45.000Z","date":"2026-06-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":88,"price":3.12,"value":274.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":31007,"source":{"system":"sec-edgar","filing":"0001437749-26-021611","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774926021611/rdgdoc.xml","form_type":"4"}},{"id":728156,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-06-25T01:00:45.000Z","date":"2026-06-22","kind":"exercise","planned":false,"acquired":true,"shares":360,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":31088,"source":{"system":"sec-edgar","filing":"0001437749-26-021611","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774926021611/rdgdoc.xml","form_type":"4"}},{"id":728155,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-06-25T01:00:45.000Z","date":"2026-06-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":37,"price":2.88,"value":106.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":30728,"source":{"system":"sec-edgar","filing":"0001437749-26-021611","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774926021611/rdgdoc.xml","form_type":"4"}},{"id":728154,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-06-25T01:00:45.000Z","date":"2026-06-20","kind":"exercise","planned":false,"acquired":true,"shares":150,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":30765,"source":{"system":"sec-edgar","filing":"0001437749-26-021611","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774926021611/rdgdoc.xml","form_type":"4"}},{"id":727612,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-06-25T01:00:21.000Z","date":"2026-06-22","kind":"exercise","planned":false,"acquired":false,"shares":174,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On June 22, 2023, the reporting person was granted 693 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On June 22, 2023, the reporting person was granted 693 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 100,003 shares of common stock underlying Series E warrants to purchase common stock."}],"balance_after":147718,"derivative":{"underlying":"Common Stock","underlying_shares":174},"source":{"system":"sec-edgar","filing":"0001437749-26-021610","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774926021610/rdgdoc.xml","form_type":"4"}},{"id":727611,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-06-25T01:00:21.000Z","date":"2026-06-20","kind":"exercise","planned":false,"acquired":false,"shares":109,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 20, 2022, the reporting person was granted 434 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 20, 2022, the reporting person was granted 434 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 100,003 shares of common stock underlying Series E warrants to purchase common stock."}],"balance_after":147892,"derivative":{"underlying":"Common Stock","underlying_shares":109},"source":{"system":"sec-edgar","filing":"0001437749-26-021610","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774926021610/rdgdoc.xml","form_type":"4"}},{"id":727610,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-25T01:00:21.000Z","date":"2026-06-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":41,"price":3.12,"value":127.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":12340,"source":{"system":"sec-edgar","filing":"0001437749-26-021610","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774926021610/rdgdoc.xml","form_type":"4"}},{"id":727609,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-25T01:00:21.000Z","date":"2026-06-22","kind":"exercise","planned":false,"acquired":true,"shares":174,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":12381,"source":{"system":"sec-edgar","filing":"0001437749-26-021610","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774926021610/rdgdoc.xml","form_type":"4"}},{"id":727608,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-25T01:00:21.000Z","date":"2026-06-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":31,"price":2.88,"value":89.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":12207,"source":{"system":"sec-edgar","filing":"0001437749-26-021610","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774926021610/rdgdoc.xml","form_type":"4"}},{"id":727607,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-25T01:00:21.000Z","date":"2026-06-20","kind":"exercise","planned":false,"acquired":true,"shares":109,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":12238,"source":{"system":"sec-edgar","filing":"0001437749-26-021610","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774926021610/rdgdoc.xml","form_type":"4"}},{"id":998859,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26233,"kind":"person","name":"PICKER DONALD H","position":1,"cik":"0001266800","reported_name":"PICKER DONALD H","relationship":{"officer":true,"officer_title":"CSO"}}],"security":"Performance Based Restricted Stock Units","published_at":"2025-11-14T21:08:46.000Z","date":"2025-11-12","kind":"grant","planned":false,"acquired":true,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one shares of Company common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On November 12, 2025, the Board approved this performance based restricted stock unit. The performance based restricted stock units set forth in this table will vest in 20% installments upon the achievement of certain clinical milestones; provided that upon a change of control (as defined in the 2024 Stock Plan) 100% shall vest."}],"balance_after":495508,"derivative":{"expiration_date":"2035-11-12","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001437749-25-035186","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925035186/rdgdoc.xml","form_type":"4"}},{"id":998858,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26233,"kind":"person","name":"PICKER DONALD H","position":1,"cik":"0001266800","reported_name":"PICKER DONALD H","relationship":{"officer":true,"officer_title":"CSO"}}],"security":"Stock option (right to buy)","published_at":"2025-11-14T21:08:46.000Z","date":"2025-11-12","kind":"grant","planned":false,"acquired":true,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date."}],"balance_after":295508,"derivative":{"exercise_price":0.49,"expiration_date":"2035-11-12","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001437749-25-035186","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925035186/rdgdoc.xml","form_type":"4"}},{"id":998857,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Performance Based Restricted Stock Units","published_at":"2025-11-14T21:08:22.000Z","date":"2025-11-12","kind":"grant","planned":false,"acquired":true,"shares":400000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one shares of Company common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On November 12, 2025, the Board approved this performance based restricted stock unit. The performance based restricted stock units set forth in this table will vest in 20% installments upon the achievement of certain clinical milestones; provided that upon a change of control (as defined in the 2024 Stock Plan) 100% shall vest."}],"balance_after":2017695,"derivative":{"expiration_date":"2035-11-12","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001437749-25-035184","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925035184/rdgdoc.xml","form_type":"4"}},{"id":998856,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Stock option (right to buy)","published_at":"2025-11-14T21:08:22.000Z","date":"2025-11-12","kind":"grant","planned":false,"acquired":true,"shares":600000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date."}],"balance_after":1617695,"derivative":{"exercise_price":0.49,"expiration_date":"2035-11-12","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001437749-25-035184","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925035184/rdgdoc.xml","form_type":"4"}},{"id":999391,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Performance Based Restricted Stock Units","published_at":"2025-11-14T21:07:49.000Z","date":"2025-11-12","kind":"grant","planned":false,"acquired":true,"shares":750000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one shares of Company common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On November 12, 2025, the Board approved this performance based restricted stock unit. The performance based restricted stock units set forth in this table will vest in 20% installments upon the achievement of certain clinical milestones; provided that upon a change of control (as defined in the 2024 Stock Plan) 100% shall vest."}],"balance_after":3960731,"derivative":{"expiration_date":"2035-11-12","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001437749-25-035182","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774925035182/rdgdoc.xml","form_type":"4"}},{"id":999390,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Stock option (right to buy)","published_at":"2025-11-14T21:07:49.000Z","date":"2025-11-12","kind":"grant","planned":false,"acquired":true,"shares":830000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date."}],"balance_after":3210731,"derivative":{"exercise_price":0.49,"expiration_date":"2035-11-12","underlying":"Common Stock","underlying_shares":830000},"source":{"system":"sec-edgar","filing":"0001437749-25-035182","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774925035182/rdgdoc.xml","form_type":"4"}},{"id":998855,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":73124,"kind":"person","name":"Cermak Elizabeth","position":1,"cik":"0001471971","reported_name":"Cermak Elizabeth","relationship":{"director":true}}],"security":"Stock Options (right to buy)","published_at":"2025-11-14T21:06:48.000Z","date":"2025-11-12","kind":"grant","planned":false,"acquired":true,"shares":150000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were issued in connection with the reporting person's Board of Director service to the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options set forth in this table vest on November 12, 2026, subject to the grantee's continued service on the Company's Board of Directors on each vesting date."}],"balance_after":164668,"derivative":{"exercise_price":0.49,"exercise_date":"2026-11-12","expiration_date":"2035-11-12","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001437749-25-035177","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925035177/rdgdoc.xml","form_type":"4"}},{"id":998854,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":73123,"kind":"person","name":"CANNON MICHAEL D","position":1,"cik":"0001203602","reported_name":"CANNON MICHAEL D","relationship":{"director":true}}],"security":"Stock Options (right to buy)","published_at":"2025-11-14T21:06:17.000Z","date":"2025-11-12","kind":"grant","planned":false,"acquired":true,"shares":150000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were issued in connection with the reporting person's Board of Director service to the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options set forth in this table vest on November 12, 2026, subject to the grantee's continued service on the Company's Board of Directors on each vesting date."}],"balance_after":165336,"derivative":{"exercise_price":0.49,"exercise_date":"2026-11-12","expiration_date":"2035-11-12","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001437749-25-035174","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925035174/rdgdoc.xml","form_type":"4"}},{"id":998853,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":72888,"kind":"person","name":"Climaco John M","position":1,"cik":"0001546797","reported_name":"Climaco John M","relationship":{"director":true}}],"security":"Stock Options (right to buy)","published_at":"2025-11-14T21:05:51.000Z","date":"2025-11-12","kind":"grant","planned":false,"acquired":true,"shares":150000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were issued in connection with the reporting person's Board of Director service to the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options set forth in this table vest on November 12, 2026, subject to the grantee's continued service on the Company's Board of Directors on each vesting date."}],"balance_after":165169,"derivative":{"exercise_price":0.49,"exercise_date":"2026-11-12","expiration_date":"2035-11-12","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001437749-25-035170","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925035170/rdgdoc.xml","form_type":"4"}},{"id":998986,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":73143,"kind":"person","name":"Yan Joy","position":1,"cik":"0001866109","reported_name":"Yan Joy","relationship":{"director":true}}],"security":"Stock Options (right to buy)","published_at":"2025-11-14T16:07:16.000Z","date":"2025-11-12","kind":"grant","planned":false,"acquired":true,"shares":150000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were issued in connection with the reporting person's Board of Director service to the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options set forth in this table vest on November 12, 2026, subject to the grantee's continued service on the Company's Board of Directors on each vesting date."}],"balance_after":164001,"derivative":{"exercise_price":0.49,"exercise_date":"2026-11-12","expiration_date":"2035-11-12","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001437749-25-035179","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866109/000143774925035179/rdgdoc.xml","form_type":"4"}},{"id":998892,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":73126,"kind":"person","name":"George Robert E.","position":1,"cik":"0001674701","reported_name":"George Robert E.","relationship":{"director":true}}],"security":"Stock Options (right to buy)","published_at":"2025-11-14T16:05:24.000Z","date":"2025-11-12","kind":"grant","planned":false,"acquired":true,"shares":150000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were issued in connection with the reporting person's Board of Director service to the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options set forth in this table vest on November 12, 2026, subject to the grantee's continued service on the Company's Board of Directors on each vesting date."}],"balance_after":165336,"derivative":{"exercise_price":0.49,"exercise_date":"2026-11-12","expiration_date":"2035-11-12","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001437749-25-035168","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674701/000143774925035168/rdgdoc.xml","form_type":"4"}},{"id":1005802,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26233,"kind":"person","name":"PICKER DONALD H","position":1,"cik":"0001266800","reported_name":"PICKER DONALD H","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Restricted Stock Units","published_at":"2025-11-07T01:25:26.000Z","date":"2025-11-04","kind":"exercise","planned":false,"acquired":false,"shares":8750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On November 4, 2024, the reporting person was granted 35,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On November 4, 2024, the reporting person was granted 35,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date"}],"balance_after":95508,"derivative":{"underlying":"Common Stock","underlying_shares":8750},"source":{"system":"sec-edgar","filing":"0001437749-25-033684","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925033684/rdgdoc.xml","form_type":"4"}},{"id":1005801,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26233,"kind":"person","name":"PICKER DONALD H","position":1,"cik":"0001266800","reported_name":"PICKER DONALD H","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2025-11-07T01:25:26.000Z","date":"2025-11-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":2131,"price":0.497,"value":1059.107,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":16771,"source":{"system":"sec-edgar","filing":"0001437749-25-033684","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925033684/rdgdoc.xml","form_type":"4"}},{"id":1005800,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26233,"kind":"person","name":"PICKER DONALD H","position":1,"cik":"0001266800","reported_name":"PICKER DONALD H","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2025-11-07T01:25:26.000Z","date":"2025-11-04","kind":"exercise","planned":false,"acquired":true,"shares":8750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":18902,"source":{"system":"sec-edgar","filing":"0001437749-25-033684","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925033684/rdgdoc.xml","form_type":"4"}},{"id":1006166,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2025-11-07T01:24:54.000Z","date":"2025-11-04","kind":"exercise","planned":false,"acquired":false,"shares":28750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On November 4, 2024, the reporting person was granted 115,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On November 4, 2024, the reporting person was granted 115,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":2380731,"derivative":{"underlying":"Common Stock","underlying_shares":28750},"source":{"system":"sec-edgar","filing":"0001437749-25-033683","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774925033683/rdgdoc.xml","form_type":"4"}},{"id":1006165,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-11-07T01:24:54.000Z","date":"2025-11-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":7001,"price":0.497,"value":3479.497,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":765356,"source":{"system":"sec-edgar","filing":"0001437749-25-033683","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774925033683/rdgdoc.xml","form_type":"4"}},{"id":1006164,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-11-07T01:24:54.000Z","date":"2025-11-04","kind":"exercise","planned":false,"acquired":true,"shares":28750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":772357,"source":{"system":"sec-edgar","filing":"0001437749-25-033683","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774925033683/rdgdoc.xml","form_type":"4"}},{"id":1005797,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-11-07T01:24:26.000Z","date":"2025-11-04","kind":"exercise","planned":false,"acquired":false,"shares":20625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On November 4, 2024, the reporting person was granted 82,500 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On November 4, 2024, the reporting person was granted 82,500 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":1017695,"derivative":{"underlying":"Common Stock","underlying_shares":20625},"source":{"system":"sec-edgar","filing":"0001437749-25-033682","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925033682/rdgdoc.xml","form_type":"4"}},{"id":1005796,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-07T01:24:26.000Z","date":"2025-11-04","kind":"exercise","planned":false,"acquired":false,"shares":5023,"price":0.497,"value":2496.431,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":303189,"source":{"system":"sec-edgar","filing":"0001437749-25-033682","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925033682/rdgdoc.xml","form_type":"4"}},{"id":1005795,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-07T01:24:26.000Z","date":"2025-11-04","kind":"exercise","planned":false,"acquired":true,"shares":20625,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":308212,"source":{"system":"sec-edgar","filing":"0001437749-25-033682","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925033682/rdgdoc.xml","form_type":"4"}},{"id":1103771,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Series E Warrants","published_at":"2025-06-23T20:35:31.000Z","date":"2025-06-23","kind":"purchase","planned":false,"acquired":false,"shares":810810,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On June 23, 2025, the reporting person acquired 270,270 shares of common stock and Series E warrants to purchase 810,810 shares of common stock at a purchase price of $0.37 per share and accompanying warrants in a public offering. The Series E warrants will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares upon exercise of the Series E warrants and will expire five years from the date of such approval."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On June 23, 2025, the reporting person acquired 270,270 shares of common stock and Series E warrants to purchase 810,810 shares of common stock at a purchase price of $0.37 per share and accompanying warrants in a public offering. The Series E warrants will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares upon exercise of the Series E warrants and will expire five years from the date of such approval."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On June 23, 2025, the reporting person acquired 270,270 shares of common stock and Series E warrants to purchase 810,810 shares of common stock at a purchase price of $0.37 per share and accompanying warrants in a public offering. The Series E warrants will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares upon exercise of the Series E warrants and will expire five years from the date of such approval."}],"balance_after":1038320,"derivative":{"exercise_price":0.37,"underlying":"Common Stock","underlying_shares":810810},"source":{"system":"sec-edgar","filing":"0001437749-25-021051","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925021051/rdgdoc.xml","form_type":"4"}},{"id":1103770,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-06-23T20:35:31.000Z","date":"2025-06-22","kind":"exercise","planned":false,"acquired":false,"shares":4328,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On June 22, 2023, the reporting person was granted 17,313 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On June 22, 2023, the reporting person was granted 17,313 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":227510,"derivative":{"underlying":"Common Stock","underlying_shares":4328},"source":{"system":"sec-edgar","filing":"0001437749-25-021051","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925021051/rdgdoc.xml","form_type":"4"}},{"id":1103769,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-06-23T20:35:31.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":false,"shares":2711,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 20, 2022, the reporting person was granted 10,846 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 20, 2022, the reporting person was granted 10,846 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":231838,"derivative":{"underlying":"Common Stock","underlying_shares":2711},"source":{"system":"sec-edgar","filing":"0001437749-25-021051","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925021051/rdgdoc.xml","form_type":"4"}},{"id":1103768,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-23T20:35:31.000Z","date":"2025-06-23","kind":"purchase","planned":false,"acquired":true,"shares":270270,"price":0.37,"value":99999.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On June 23, 2025, the reporting person acquired 270,270 shares of common stock and Series E warrants to purchase 810,810 shares of common stock at a purchase price of $0.37 per share and accompanying warrants in a public offering. The Series E warrants will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares upon exercise of the Series E warrants and will expire five years from the date of such approval."}],"balance_after":287587,"source":{"system":"sec-edgar","filing":"0001437749-25-021051","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925021051/rdgdoc.xml","form_type":"4"}},{"id":1103767,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-23T20:35:31.000Z","date":"2025-06-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":1054,"price":0.267,"value":281.418,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":17317,"source":{"system":"sec-edgar","filing":"0001437749-25-021051","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925021051/rdgdoc.xml","form_type":"4"}},{"id":1103766,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-23T20:35:31.000Z","date":"2025-06-22","kind":"exercise","planned":false,"acquired":true,"shares":4328,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":18371,"source":{"system":"sec-edgar","filing":"0001437749-25-021051","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925021051/rdgdoc.xml","form_type":"4"}},{"id":1103765,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-23T20:35:31.000Z","date":"2025-06-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":661,"price":0.267,"value":176.487,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":14043,"source":{"system":"sec-edgar","filing":"0001437749-25-021051","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925021051/rdgdoc.xml","form_type":"4"}},{"id":1103764,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-23T20:35:31.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":true,"shares":2711,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":14704,"source":{"system":"sec-edgar","filing":"0001437749-25-021051","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925021051/rdgdoc.xml","form_type":"4"}},{"id":1104268,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Series E Warrants","published_at":"2025-06-23T20:35:11.000Z","date":"2025-06-23","kind":"purchase","planned":false,"acquired":false,"shares":2027025,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On June 23, 2025, the reporting person acquired 675,675 shares of common stock and Series E warrants to purchase 2,027,025 shares of common stock at a purchase price of $0.37 per share and accompanying warrants in a public offering. The Series E warrants will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares upon exercise of the Series E warrants and will expire five years from the date of such approval."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On June 23, 2025, the reporting person acquired 675,675 shares of common stock and Series E warrants to purchase 2,027,025 shares of common stock at a purchase price of $0.37 per share and accompanying warrants in a public offering. The Series E warrants will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares upon exercise of the Series E warrants and will expire five years from the date of such approval."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On June 23, 2025, the reporting person acquired 675,675 shares of common stock and Series E warrants to purchase 2,027,025 shares of common stock at a purchase price of $0.37 per share and accompanying warrants in a public offering. The Series E warrants will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares upon exercise of the Series E warrants and will expire five years from the date of such approval."}],"balance_after":2409481,"derivative":{"exercise_price":0.37,"underlying":"Common Stock","underlying_shares":2027025},"source":{"system":"sec-edgar","filing":"0001437749-25-021050","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774925021050/rdgdoc.xml","form_type":"4"}},{"id":1104267,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2025-06-23T20:35:11.000Z","date":"2025-06-22","kind":"exercise","planned":false,"acquired":false,"shares":8990,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On June 22, 2023, the reporting person was granted 35,959 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On June 22, 2023, the reporting person was granted 35,959 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":382456,"derivative":{"underlying":"Common Stock","underlying_shares":8990},"source":{"system":"sec-edgar","filing":"0001437749-25-021050","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774925021050/rdgdoc.xml","form_type":"4"}},{"id":1104266,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2025-06-23T20:35:11.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 20, 2022, the reporting person was granted 15,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 20, 2022, the reporting person was granted 15,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":391446,"derivative":{"underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001437749-25-021050","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774925021050/rdgdoc.xml","form_type":"4"}},{"id":1104265,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-06-23T20:35:11.000Z","date":"2025-06-23","kind":"purchase","planned":false,"acquired":true,"shares":675675,"price":0.37,"value":249999.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On June 23, 2025, the reporting person acquired 675,675 shares of common stock and Series E warrants to purchase 2,027,025 shares of common stock at a purchase price of $0.37 per share and accompanying warrants in a public offering. The Series E warrants will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares upon exercise of the Series E warrants and will expire five years from the date of such approval."}],"balance_after":743607,"source":{"system":"sec-edgar","filing":"0001437749-25-021050","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774925021050/rdgdoc.xml","form_type":"4"}},{"id":1104264,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-06-23T20:35:11.000Z","date":"2025-06-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":2190,"price":0.267,"value":584.73,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":67932,"source":{"system":"sec-edgar","filing":"0001437749-25-021050","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774925021050/rdgdoc.xml","form_type":"4"}},{"id":1104263,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-06-23T20:35:11.000Z","date":"2025-06-22","kind":"exercise","planned":false,"acquired":true,"shares":8990,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":70122,"source":{"system":"sec-edgar","filing":"0001437749-25-021050","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774925021050/rdgdoc.xml","form_type":"4"}},{"id":1104262,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-06-23T20:35:11.000Z","date":"2025-06-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":914,"price":0.267,"value":244.038,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":61132,"source":{"system":"sec-edgar","filing":"0001437749-25-021050","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774925021050/rdgdoc.xml","form_type":"4"}},{"id":1104261,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-06-23T20:35:11.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":true,"shares":3750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":62046,"source":{"system":"sec-edgar","filing":"0001437749-25-021050","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774925021050/rdgdoc.xml","form_type":"4"}},{"id":1103763,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26233,"kind":"person","name":"PICKER DONALD H","position":1,"cik":"0001266800","reported_name":"PICKER DONALD H","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Restricted Stock Units","published_at":"2025-06-23T20:34:52.000Z","date":"2025-06-22","kind":"exercise","planned":false,"acquired":false,"shares":1766,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On June 22, 2023, the reporting person was granted 7,063 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On June 22, 2023, the reporting person was granted 7,063 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":104258,"derivative":{"underlying":"Common Stock","underlying_shares":1766},"source":{"system":"sec-edgar","filing":"0001437749-25-021049","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925021049/rdgdoc.xml","form_type":"4"}},{"id":1103762,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26233,"kind":"person","name":"PICKER DONALD H","position":1,"cik":"0001266800","reported_name":"PICKER DONALD H","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Restricted Stock Units","published_at":"2025-06-23T20:34:52.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":false,"shares":1078,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 20, 2022, the reporting person was granted 4,312 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 20, 2022, the reporting person was granted 4,312 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":106024,"derivative":{"underlying":"Common Stock","underlying_shares":1078},"source":{"system":"sec-edgar","filing":"0001437749-25-021049","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925021049/rdgdoc.xml","form_type":"4"}},{"id":1103761,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26233,"kind":"person","name":"PICKER DONALD H","position":1,"cik":"0001266800","reported_name":"PICKER DONALD H","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2025-06-23T20:34:52.000Z","date":"2025-06-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":430,"price":0.267,"value":114.81,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":10152,"source":{"system":"sec-edgar","filing":"0001437749-25-021049","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925021049/rdgdoc.xml","form_type":"4"}},{"id":1103760,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26233,"kind":"person","name":"PICKER DONALD H","position":1,"cik":"0001266800","reported_name":"PICKER DONALD H","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2025-06-23T20:34:52.000Z","date":"2025-06-22","kind":"exercise","planned":false,"acquired":true,"shares":1766,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":10582,"source":{"system":"sec-edgar","filing":"0001437749-25-021049","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925021049/rdgdoc.xml","form_type":"4"}},{"id":1103759,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26233,"kind":"person","name":"PICKER DONALD H","position":1,"cik":"0001266800","reported_name":"PICKER DONALD H","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2025-06-23T20:34:52.000Z","date":"2025-06-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":263,"price":0.267,"value":70.221,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":8816,"source":{"system":"sec-edgar","filing":"0001437749-25-021049","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925021049/rdgdoc.xml","form_type":"4"}},{"id":1103758,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26233,"kind":"person","name":"PICKER DONALD H","position":1,"cik":"0001266800","reported_name":"PICKER DONALD H","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2025-06-23T20:34:52.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":true,"shares":1078,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":9079,"source":{"system":"sec-edgar","filing":"0001437749-25-021049","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925021049/rdgdoc.xml","form_type":"4"}},{"id":1106293,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-06-19T01:01:07.000Z","date":"2025-06-16","kind":"exercise","planned":false,"acquired":false,"shares":833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 16, 2021, the reporting person was granted 3,334 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 16, 2021, the reporting person was granted 3,334 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":230684,"derivative":{"underlying":"Common Stock","underlying_shares":833},"source":{"system":"sec-edgar","filing":"0001437749-25-020803","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925020803/rdgdoc.xml","form_type":"4"}},{"id":1106292,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-19T01:01:07.000Z","date":"2025-06-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":203,"price":0.6852,"value":139.0956,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":11993,"source":{"system":"sec-edgar","filing":"0001437749-25-020803","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925020803/rdgdoc.xml","form_type":"4"}},{"id":1106291,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-19T01:01:07.000Z","date":"2025-06-16","kind":"exercise","planned":false,"acquired":true,"shares":833,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":12196,"source":{"system":"sec-edgar","filing":"0001437749-25-020803","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925020803/rdgdoc.xml","form_type":"4"}},{"id":1106860,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2025-06-19T01:00:17.000Z","date":"2025-06-16","kind":"exercise","planned":false,"acquired":false,"shares":1667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 16, 2021, the reporting person was granted 6,668 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 16, 2021, the reporting person was granted 6,668 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":370075,"derivative":{"underlying":"Common Stock","underlying_shares":1667},"source":{"system":"sec-edgar","filing":"0001437749-25-020802","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774925020802/rdgdoc.xml","form_type":"4"}},{"id":1106859,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-06-19T01:00:17.000Z","date":"2025-06-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":406,"price":0.6852,"value":278.1912,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards"}],"balance_after":58296,"source":{"system":"sec-edgar","filing":"0001437749-25-020802","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774925020802/rdgdoc.xml","form_type":"4"}},{"id":1106858,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-06-19T01:00:17.000Z","date":"2025-06-16","kind":"exercise","planned":false,"acquired":true,"shares":1667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":58702,"source":{"system":"sec-edgar","filing":"0001437749-25-020802","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774925020802/rdgdoc.xml","form_type":"4"}},{"id":1374203,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":73124,"kind":"person","name":"Cermak Elizabeth","position":1,"cik":"0001471971","reported_name":"Cermak Elizabeth","relationship":{"director":true}}],"security":"Stock option (right to buy)","published_at":"2024-11-07T01:05:23.000Z","date":"2024-11-04","kind":"grant","planned":false,"acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were issued in connection with the reporting person's Board of Director service to the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options set forth in this table vest through April 2025, subject to the grantee's continued service on the Company's Board of Directors on each vesting date."}],"balance_after":14668,"derivative":{"exercise_price":2.45,"expiration_date":"2034-11-04","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-24-033709","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774924033709/rdgdoc.xml","form_type":"4"}},{"id":1374202,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":72888,"kind":"person","name":"Climaco John M","position":1,"cik":"0001546797","reported_name":"Climaco John M","relationship":{"director":true}}],"security":"Stock option (right to buy)","published_at":"2024-11-07T01:04:49.000Z","date":"2024-11-04","kind":"grant","planned":false,"acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were issued in connection with the reporting person's Board of Director service to the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options set forth in this table vest through April 2025, subject to the grantee's continued service on the Company's Board of Directors on each vesting date."}],"balance_after":15169,"derivative":{"exercise_price":2.45,"expiration_date":"2034-11-04","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-24-033708","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774924033708/rdgdoc.xml","form_type":"4"}},{"id":1374201,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":73123,"kind":"person","name":"CANNON MICHAEL D","position":1,"cik":"0001203602","reported_name":"CANNON MICHAEL D","relationship":{"director":true}}],"security":"Stock option (right to buy)","published_at":"2024-11-07T01:03:07.000Z","date":"2024-11-04","kind":"grant","planned":false,"acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were issued in connection with the reporting person's Board of Director service to the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options set forth in this table vest through April 2025, subject to the grantee's continued service on the Company's Board of Directors on each vesting date."}],"balance_after":15336,"derivative":{"exercise_price":2.45,"expiration_date":"2034-11-04","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-24-033706","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774924033706/rdgdoc.xml","form_type":"4"}},{"id":1374197,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26233,"kind":"person","name":"PICKER DONALD H","position":1,"cik":"0001266800","reported_name":"PICKER DONALD H","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Performance Based Restricted Stock Units","published_at":"2024-11-07T01:03:06.000Z","date":"2024-10-25","kind":"grant","planned":false,"acquired":true,"shares":5744,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one shares of Company common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On December 29, 2023, the Board approved this performance based restricted stock unit, subject to shareholder approval of the stock plan. The performance based restricted stock units set forth in this table will vest only upon both (A) the approval of the Plan Amendment by the Company stockholders; and (B) the first of the following to occur: (a) a licensing transaction with a valuation, at the time, in excess of $150 million, which valuation shall be determined by the Board; (b) the filing of a new drug application; or (c) upon a Change in Control (as defined in the Plan), in each case subject to the respective executive officer's continued service with the Company at each such vesting date."}],"balance_after":107102,"derivative":{"expiration_date":"2033-12-29","underlying":"Common Stock","underlying_shares":5744},"source":{"system":"sec-edgar","filing":"0001437749-24-033705","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774924033705/rdgdoc.xml","form_type":"4"}},{"id":1374196,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26233,"kind":"person","name":"PICKER DONALD H","position":1,"cik":"0001266800","reported_name":"PICKER DONALD H","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Restricted Stock Units","published_at":"2024-11-07T01:03:06.000Z","date":"2024-11-04","kind":"grant","planned":false,"acquired":true,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one shares of Company common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date."}],"balance_after":101358,"derivative":{"underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001437749-24-033705","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774924033705/rdgdoc.xml","form_type":"4"}},{"id":1374195,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26233,"kind":"person","name":"PICKER DONALD H","position":1,"cik":"0001266800","reported_name":"PICKER DONALD H","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Stock option (right to buy)","published_at":"2024-11-07T01:03:06.000Z","date":"2024-11-04","kind":"grant","planned":false,"acquired":true,"shares":40000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date."}],"balance_after":66358,"derivative":{"exercise_price":2.45,"expiration_date":"2034-11-04","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001437749-24-033705","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774924033705/rdgdoc.xml","form_type":"4"}},{"id":1374200,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Performance Based Restricted Stock Units","published_at":"2024-11-07T01:00:49.000Z","date":"2024-10-25","kind":"grant","planned":false,"acquired":true,"shares":19180,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one shares of Company common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On December 29, 2023, the Board approved this performance based restricted stock unit, subject to shareholder approval of the stock plan. The performance based restricted stock units set forth in this table will vest only upon both (A) the approval of the Plan Amendment by the Company stockholders; and (B) the first of the following to occur: (a) a licensing transaction with a valuation, at the time, in excess of $150 million, which valuation shall be determined by the Board; (b) the filing of a new drug application; or (c) upon a Change in Control (as defined in the Plan), in each case subject to the respective executive officer's continued service with the Company at each such vesting date."}],"balance_after":231517,"derivative":{"expiration_date":"2033-12-29","underlying":"Common Stock","underlying_shares":19180},"source":{"system":"sec-edgar","filing":"0001437749-24-033704","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774924033704/rdgdoc.xml","form_type":"4"}},{"id":1374199,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-11-07T01:00:49.000Z","date":"2024-11-04","kind":"grant","planned":false,"acquired":true,"shares":82500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one shares of Company common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date."}],"balance_after":212337,"derivative":{"underlying":"Common Stock","underlying_shares":82500},"source":{"system":"sec-edgar","filing":"0001437749-24-033704","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774924033704/rdgdoc.xml","form_type":"4"}},{"id":1374198,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2024-11-07T01:00:49.000Z","date":"2024-11-04","kind":"grant","planned":false,"acquired":true,"shares":65000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date."}],"balance_after":129837,"derivative":{"exercise_price":2.45,"expiration_date":"2034-11-04","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001437749-24-033704","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774924033704/rdgdoc.xml","form_type":"4"}},{"id":1374582,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Performance Based Restricted Stock Units","published_at":"2024-11-07T01:00:17.000Z","date":"2024-10-25","kind":"grant","planned":false,"acquired":true,"shares":43590,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one shares of Company common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On December 29, 2023, the Board approved this performance based restricted stock unit, subject to shareholder approval of the stock plan. The performance based restricted stock units set forth in this table will vest only upon both (A) the approval of the Plan Amendment by the Company stockholders; and (B) the first of the following to occur: (a) a licensing transaction with a valuation, at the time, in excess of $150 million, which valuation shall be determined by the Board; (b) the filing of a new drug application; or (c) upon a Change in Control (as defined in the Plan), in each case subject to the respective executive officer's continued service with the Company at each such vesting date."}],"balance_after":371742,"derivative":{"expiration_date":"2033-12-29","underlying":"Common Stock","underlying_shares":43590},"source":{"system":"sec-edgar","filing":"0001437749-24-033703","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774924033703/rdgdoc.xml","form_type":"4"}},{"id":1374581,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2024-11-07T01:00:17.000Z","date":"2024-11-04","kind":"grant","planned":false,"acquired":true,"shares":115000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one shares of Company common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date."}],"balance_after":328152,"derivative":{"underlying":"Common Stock","underlying_shares":115000},"source":{"system":"sec-edgar","filing":"0001437749-24-033703","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774924033703/rdgdoc.xml","form_type":"4"}},{"id":1374580,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Stock option (right to buy)","published_at":"2024-11-07T01:00:17.000Z","date":"2024-11-04","kind":"grant","planned":false,"acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date."}],"balance_after":213152,"derivative":{"exercise_price":2.45,"expiration_date":"2024-11-04","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001437749-24-033703","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774924033703/rdgdoc.xml","form_type":"4"}},{"id":1374352,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":73143,"kind":"person","name":"Yan Joy","position":1,"cik":"0001866109","reported_name":"Yan Joy","relationship":{"director":true}}],"security":"Stock option (right to buy)","published_at":"2024-11-06T20:06:10.000Z","date":"2024-11-04","kind":"grant","planned":false,"acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were issued in connection with the reporting person's Board of Director service to the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options set forth in this table vest through April 2025, subject to the grantee's continued service on the Company's Board of Directors on each vesting date."}],"balance_after":14001,"derivative":{"exercise_price":2.45,"expiration_date":"2034-11-04","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-24-033710","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866109/000143774924033710/rdgdoc.xml","form_type":"4"}},{"id":1374219,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":73126,"kind":"person","name":"George Robert E.","position":1,"cik":"0001674701","reported_name":"George Robert E.","relationship":{"director":true}}],"security":"Stock option (right to buy)","published_at":"2024-11-06T20:03:56.000Z","date":"2024-11-04","kind":"grant","planned":false,"acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were issued in connection with the reporting person's Board of Director service to the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options set forth in this table vest through April 2025, subject to the grantee's continued service on the Company's Board of Directors on each vesting date."}],"balance_after":15336,"derivative":{"exercise_price":2.45,"expiration_date":"2034-11-04","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-24-033707","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674701/000143774924033707/rdgdoc.xml","form_type":"4"}},{"id":1459035,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2024-07-05T21:01:18.000Z","date":"2024-07-02","kind":"exercise","planned":false,"acquired":false,"shares":982,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 2, 2020, the reporting person was granted 3,926 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On July 2, 2020, the reporting person was granted 3,926 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":113152,"derivative":{"underlying":"Common Stock","underlying_shares":982},"source":{"system":"sec-edgar","filing":"0001437749-24-022252","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774924022252/rdgdoc.xml","form_type":"4"}},{"id":1459034,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-07-05T21:01:18.000Z","date":"2024-07-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":240,"price":3.57,"value":856.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":57035,"source":{"system":"sec-edgar","filing":"0001437749-24-022252","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774924022252/rdgdoc.xml","form_type":"4"}},{"id":1459033,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-07-05T21:01:18.000Z","date":"2024-07-02","kind":"exercise","planned":false,"acquired":true,"shares":982,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":57275,"source":{"system":"sec-edgar","filing":"0001437749-24-022252","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774924022252/rdgdoc.xml","form_type":"4"}},{"id":1469506,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26233,"kind":"person","name":"PICKER DONALD H","position":1,"cik":"0001266800","reported_name":"PICKER DONALD H","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Restricted Stock Units","published_at":"2024-06-25T22:02:39.000Z","date":"2024-06-22","kind":"exercise","planned":false,"acquired":false,"shares":1766,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 22, 2023, the reporting person was granted 7,063 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 22, 2023, the reporting person was granted 7,063 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":26358,"derivative":{"underlying":"Common Stock","underlying_shares":1766},"source":{"system":"sec-edgar","filing":"0001437749-24-021199","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774924021199/rdgdoc.xml","form_type":"4"}},{"id":1469505,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26233,"kind":"person","name":"PICKER DONALD H","position":1,"cik":"0001266800","reported_name":"PICKER DONALD H","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2024-06-25T22:02:39.000Z","date":"2024-06-22","kind":"tax_withholding","planned":false,"acquired":true,"shares":524,"price":3.74,"value":1959.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":8001,"source":{"system":"sec-edgar","filing":"0001437749-24-021199","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774924021199/rdgdoc.xml","form_type":"4"}},{"id":1469504,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26233,"kind":"person","name":"PICKER DONALD H","position":1,"cik":"0001266800","reported_name":"PICKER DONALD H","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2024-06-25T22:02:39.000Z","date":"2024-06-22","kind":"exercise","planned":false,"acquired":true,"shares":1766,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":8525,"source":{"system":"sec-edgar","filing":"0001437749-24-021199","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774924021199/rdgdoc.xml","form_type":"4"}},{"id":1469503,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-06-25T22:01:53.000Z","date":"2024-06-22","kind":"exercise","planned":false,"acquired":false,"shares":4329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 22, 2023, the reporting person was granted 17,313 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 22, 2023, the reporting person was granted 17,313 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":64837,"derivative":{"underlying":"Common Stock","underlying_shares":4329},"source":{"system":"sec-edgar","filing":"0001437749-24-021198","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774924021198/rdgdoc.xml","form_type":"4"}},{"id":1469502,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-06-25T22:01:53.000Z","date":"2024-06-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":1053,"price":3.74,"value":3938.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":11363,"source":{"system":"sec-edgar","filing":"0001437749-24-021198","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774924021198/rdgdoc.xml","form_type":"4"}},{"id":1469501,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-06-25T22:01:53.000Z","date":"2024-06-22","kind":"exercise","planned":false,"acquired":true,"shares":4329,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":12416,"source":{"system":"sec-edgar","filing":"0001437749-24-021198","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774924021198/rdgdoc.xml","form_type":"4"}},{"id":1469914,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2024-06-25T22:00:56.000Z","date":"2024-06-22","kind":"exercise","planned":false,"acquired":false,"shares":8990,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 22, 2023, the reporting person was granted 35,959 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 22, 2023, the reporting person was granted 35,959 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":114134,"derivative":{"underlying":"Common Stock","underlying_shares":8990},"source":{"system":"sec-edgar","filing":"0001437749-24-021197","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774924021197/rdgdoc.xml","form_type":"4"}},{"id":1469913,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-06-25T22:00:56.000Z","date":"2024-06-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":2190,"price":3.74,"value":8190.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":56293,"source":{"system":"sec-edgar","filing":"0001437749-24-021197","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774924021197/rdgdoc.xml","form_type":"4"}},{"id":1469912,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26374,"kind":"person","name":"KLEMP WALTER V","position":1,"cik":"0000938419","reported_name":"KLEMP WALTER V","relationship":{"director":true,"officer":true,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-06-25T22:00:56.000Z","date":"2024-06-22","kind":"exercise","planned":false,"acquired":true,"shares":8990,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":58483,"source":{"system":"sec-edgar","filing":"0001437749-24-021197","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/938419/000143774924021197/rdgdoc.xml","form_type":"4"}},{"id":1472027,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26233,"kind":"person","name":"PICKER DONALD H","position":1,"cik":"0001266800","reported_name":"PICKER DONALD H","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Restricted Stock Units","published_at":"2024-06-21T21:01:55.000Z","date":"2024-06-20","kind":"exercise","planned":false,"acquired":false,"shares":1078,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 20, 2022, the reporting person was granted 4,312 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 20, 2022, the reporting person was granted 4,312 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":28124,"derivative":{"underlying":"Common Stock","underlying_shares":1078},"source":{"system":"sec-edgar","filing":"0001437749-24-020997","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774924020997/rdgdoc.xml","form_type":"4"}},{"id":1472026,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26233,"kind":"person","name":"PICKER DONALD H","position":1,"cik":"0001266800","reported_name":"PICKER DONALD H","relationship":{"officer":true,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2024-06-21T21:01:55.000Z","date":"2024-06-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":320,"price":3.78,"value":1209.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":6759,"source":{"system":"sec-edgar","filing":"0001437749-24-020997","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774924020997/rdgdoc.xml","form_type":"4"}}],"next_cursor":"2024-06-21T21:01:55.000000Z,1472026"}